Loading organizations...

§ Venture Capital · New York City, NY, USA
Venture capital firm investing in innovations for women's health across therapeutics, devices, digital health, and diagnostics.
FemHealth Ventures is a venture capital firm that invests in healthcare innovations advancing women's health across therapeutics, medical devices, digital health, artificial intelligence, and diagnostics. The firm targets businesses addressing medical conditions that exclusively affect women, disproportionately impact women, or manifest differently in female patients, such as endometriosis, breast cancer, heart disease, and uterine fibroids. While specific fund metrics remain undisclosed, the firm's leadership has previously deployed over $1 billion into public and private healthcare companies. The firm's advisory board features prominent industry figures including healthcare royalty investing pioneer Greg Brown, Harvard Business School professor Randy Cohen, and breast cancer surgeon Rache Simmons. Its investment portfolio includes companies like Gynesonics, a medical device manufacturer that was recently acquired by Hologic. The venture capital firm was founded by managing partners Maneesha Ghiya and Noraan Sadik.
FemHealth Ventures has 1 tracked investment across 1 company. The latest tracked deal is $103.0M Series A in Reunion Neuroscience in May 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 2, 2024 | Reunion Neuroscience | $103.0M Series A | Ansbert Gadicke, Natalie Sacks | Arkin BIO Ventures, Mitsui & CO. Global Investment, Palo Santo, Plaisance Capital Management |